Open AccessWhich hematological markers have predictive value as early indicators of severe COVID-19 cases in the emergency department?
Author(s) -
İ̇shak Şan,
Emin Gemcioğlu,
Mehmet Davutoğlu,
Ramis Catalbas,
Berkan Karabuga,
Enes Kaptan,
Abdülsamet Erden,
Orhan Küçükşahin,
İhsan Ateş,
Selma Karaahmetoğlu,
İmran Hasanoğlu,
Osman İnan,
BÜSra Nur Ünal,
Ecem ErdemIr,
Fatih Kahraman,
Rahmet Güner
Publication year - 2021
Publication title -
turkish journal of medical sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.277
H-Index - 27
eISSN - 1303-6165
pISSN - 1300-0144
DOI - 10.3906/sag-2008-6
Subject(s) - medicine , emergency department , covid-19 , predictive value , emergency medicine , medical emergency , virology , disease , outbreak , infectious disease (medical specialty) , psychiatry
Coronavirus 2019 disease (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a pandemic infectious disease that causes morbidity and mortality. As a result of high mortality rate among the severe COVID-19 patients, the early detection of the disease stage and early effective interventions are very important in reducing mortality. Hence, it is important to differentiate severe and nonsevere cases from each other. To date, there are no proven diagnostic or prognostic parameters that can be used in this manner. Due to the expensive and not easily accessible tests that are performed for COVID-19, researchers are investigating some parameters that can be easily used. In some recent studies, hematological parameters have been evaluated to see if they can be used as predictive parameters.